In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Inspire Medical nets $70.5mm via follow-on

Executive Summary

Inspire Medical Systems Inc. (implantable neurostimulation device for patients with obstructive sleep apnea) netted $70.5mm through the follow-on sale of 1.88mm common shares (including full exercise of the overallotment) at $40 each. Stockholders sold another 1mm shares. The company plans to use the funds to hire sales and marketing personnel and expand marketing programs in the US, Europe, and Japan, for R&D activities, and for potential acquisitions or partnership opportunities.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register